ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
Open Access
Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care
Date:
29 April 2020
Journal:
European Heart Journal , Volume 41 , Issue 25 , Pages 2393 - 2396
Topic:
HEART FAILURE, Chronic Heart Failure, BASIC SCIENCE
Author:
M. Packer
Read Full Article
ESC Journals
Add to my library
Like
About the contributors
Milton Packer
Role:
Author
ESC 365 is supported by
Explore sponsored resources
Explore sponsored resources